SBIR/STTR Research Award

SYNTHESES FOR PRODUCTION OF INOSITOLPHOSPHOLIPIDS

Award identifier 20fe0a005cda62731c35801d57c9f783eeb659299cc4bdffe3aa1e7f6efb15b2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$0

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NUTRIMED BIOTECH
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Description: (Applicant's abstract): Inositolphospholipids are an important group of biological amphiphilic phospholipids. The group includes phosphatidylinositols (PtdIns) and its radyl and sphingo analogues. Members of the group are critical intracellular signaling messengers, and important as biomedical research reagents and for developing diagnostics and therapeutics based on signaling modalities. Furthermore, inositolphospholipids are biocompatible amphiphiles with applications in skin-care and intravenous drug delivery formulations. No practical approach adaptable for economical large scale production is available. The overall objective of this investigation is to develop laboratory scale methods of synthesis, potentially adaptable for economical larger scale production, for preparing individual molecular species of PtdIns and analogous inositolphospholipids. During Phase I, a novel approach, applicable to the entire biological PtdIns group and tailored analogues, was experimentally validated for PtdIns synthesis, and the structural and stereochemical integrity of the products was established unequivocally. During Phase II, this approach to synthesis will be optimized for ultimate economical larger scale production of PtdIns, and extended to radyl, sphingolipid, thiophosphate and phosphonate type analogues and selected diastereomers. Further, the approach will be exploited for the preparation of selected inositolphospholipid molecular species. PROPOSED COMMERCIAL APPLICATION: Not Available

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.